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Summary 
Cross-linking B cell antigen receptor (BCR) elicits  early signal  transduction events, including 
activation of protein tyrosine kinases,  phosphorylation of receptor components, activation of 
phospholipase C-~ (PLC-~/),  and increases in intracellular free Ca  2+. In this article, we report 
that  cross-linking the BCIL led to  a  rapid translocation of cytosolic protein tyrosine phos- 
phatase (PTP) 1C to the particulate fraction, where it became associated with a 140-150-kD 
tyrosyl-phosphorylated protein. Western blotting analysis identified this  140-150-kD protein 
to be CD22. The association of PTP-1C with CD22 was mediated by the NHz-terminal Src- 
homology 2  (SH2) domain of PTP-1C. Complexes of either CD22/PTP-1C/Syk or CD22/ 
PTP-1C/Syk/PLC-~/1  could be isolated from B  cells  stimulated by BCR  engagement or a 
mixture of hydrogen peroxide and sodium orthovanadate, respectively. The binding of PLC-~/1 
and Syk to tyrosyl-phosphorylated CD22 was mediated by the NH2-terminal SH2 domain of 
PLC-~/1  and  the  COOH-terminal  SH2  domain  of Syk,  respectively.  These  observations 
suggest that tyrosyl-phosphorylated CD22 may provide the scaffolding to ensure efficient inter- 
action between Syk and PLC-'y1 and the activation of PLC-~/1 by Syk. The recruitment of 
PTP-1C  to BCR-associated CD22  may downmodulate the activity of this  complex by de- 
phosphorylation ofCD22, Syk, and/or PLC-~I. Transient expression of CD22 and a null mu- 
tant of PTP-1C (PTP-1C  M) in COS cells resulted in an increase in tyrosyl phosphorylation of 
CD22 and its interaction with PTP-1C  M. By contrast, CD22 was not tyrosyl phosphorylated 
or associated with PTP-1C  M in the presence of wild-type PTP-1C. These results  suggest that 
tyrosyl-phosphorylated CD22 may be a substrate for PTP-1C or that PTP-1C regulates tyrosyl 
phosphorylation of CD22. 
L 
igation of the B  cell antigen receptor (BCR) 1 induces 
activation of the BCR-associated protein tyrosine ki- 
nases (PTKs), tyrosyl phosphorylation ofphospholipase C-~/ 
(PLC-~/), and increases in intracellular free Ca  2+  ([Ca2+]i) 
(1,  2).  Accessory molecules such as CD45,  CD19,  CD21, 
and CD22 have also been implicated to play essential  regu- 
latory functions in BCR-mediated signal transduction (3-5). 
One BCR-associated PTK activated upon BCR engage- 
ment, Syk, has been linked to the activation of PLC-~/iso- 
1Abbreviations used in this paper: BCR, B cell  antigen receptor;  [Ca2+]i, in- 
tracellular free calcium; GST, glutathione S-transferase;  HA, hemaggluti- 
nin; IP, immunoprecipitates;  ITAM, immunoreceptor  tyrosine-based  ac- 
tivation motiF, ITIM, immunoreceptor  tyrosine--based  inhibitory motiF, 
MBP, maltose-binding protein; PI3K, phosphatidylinositol 3-kinase; 
PLC-~, phospholipase C-~; PTK, protein tyrosine kinase; PTP, protein 
tyrosine phosphatase; PY, phosphotyrosine;  SH2, Src-homology  2. 
forms  and  increases  in  [Ca2+]i.  First,  cross-linking  of a 
CD16-Syk  chimera  induces  Ca  2+  fluxes  in  cytotoxic T 
cells (6) and basophils (7). Second, deletion of the Syk gene 
in  a  chicken B  cell line, DT40,  eliminated the  ability of 
these  cells  to  phosphorylate PLC-~/2  on  tyrosine and  to 
generate a Ca  2+ signal upon BCR cross-linking (8). Third, 
PLC-~/1 can form a complex with Syk and a 120-kD phos- 
phoprotein in human B cells (9). The interaction between 
Syk and PLC-~/1 is mediated by the interaction of the Src- 
homology 2 (SH2) domains of PLC-~/1 with tyrosyl-phos- 
phorylated Syk (10).  The significance of this interaction is 
evident by our recent observation that Syk can phosphory- 
late  PLC-~/1  on a key regulatory tyrosyl residue in vitro 
and that a direct physical contact between the two is critical 
for this reaction to occur in vivo (11). 
CD22, a 140-150-kD glycophosphoprotein restricted to 
the  B  cell lineage,  regulates BCR-mediated  signal  trans- 
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is a sialic  acid-binding animal lectin  (12).  A  small portion 
of cell surface CD22 molecules is associated with the BCtL, 
and  cross-linking of the BCtL induces rapid tyrosyl phos- 
phorylation  of CD22 at a rate  similar  to the  activation  of 
BCR-associated  PTKs  (13-15).  Cross-linking  CD22  on 
human B  cells  also potentiates  BCIk-induced increases  in 
[Ca/+]i and cell proliferation (16, 17). These studies suggest 
that a functional relationship  exists between CD22 and the 
BCR. However, how CD22 regulates BCR-mediated sig- 
nal transduction remains to be defined. 
Recent  studies  have  shown that protein  tyrosine phos- 
phatases (PTPs)  can dowmnodulate receptor-mediated sig- 
nal transduction  (18,  19).  PTP-1C  contains  two  SH2  do- 
mains  in  the  NH2-terminal  half of the  molecule  and  is 
expressed in multiple hematopoietic lineages  (20-23).  This 
enzyme is essential for the  development and normal func- 
tion of the  hematopoietic  system.  Mutations  in the Ptp-lc 
gene lead to hematopoietic abnormalities in motheaten  (me/ 
me)  and motheaten viable  (me~/me  v) mice (24, 25),  including 
elevated granulocyte and macrophage activities,  erythrocy- 
tosis,  and decreased NK and T  cell activity (26).  PTP-1C 
has been described as interacting functionally with multiple 
receptors  in  different  hematopoietic  lineages,  including 
those  for  erythropoietin-1  (EPO-1)  (27,  28),  IL-3  (29), 
stem cell factor (30), and CSF-1  (31). The defects in the B 
cell lineage  of the  me~me and meV/me  ~ mice are character- 
ized  by a  severe  reduction  in  conventional B  cells  com- 
pounded  with  profound  systemic  autoimmunity  (32). 
These defects in the B  cell compartment may be related to 
the functions of PTP-1C in regulating B  cell activation,  as 
PTP-1C  can interact  with  both  the  Fo/IIB receptor  (33) 
and components of the BCtL complex (34,  35)  and influ- 
ences the threshold of antigen required  for negative selec- 
tion of B cells (36). 
Herein,  we report that CD22 plays a central role for the 
in vivo formation ofa mulfimolecular complex with PTP-1C, 
Syk, and PLC-~/1. The binding of these enzymes to CD22 
is mediated by their SH2 domains, Moreover, we also pro- 
vide  evidence  suggesting that  PTP-1C  can  dephosphory- 
late  CD22.  This would provide a potential  mechanism to 
downmodulate the BCK-mediated Ca  2§ signal. 
Materials and Methods 
Cells and Antibodies.  The Burkitt's lymphoma cell line Daudi 
was  maintained  in  tLPMI  1640  supplemented  with  10%  FCS, 
L-glutamine,  nonessential  amino  acids,  sodium  pyruvate,  and 
penicillin-streptomycin.  COS cells were maintained in DMEM 
supplemented with the same additives.  Hybridomas secreting  the 
CD22 mAb HD39 and the CD19 mAb HD37 were kindly pro- 
vided by Dr.  Anthony Pezzutto  (Universitiit  Heidelberg,  Ger- 
many). Antiphosphotyrosine (PY) mAb PY-20, rabbit  anti-Csk, 
rabbit anti-Lyn serum, and rabbit anti-Syk serum were purchased 
from Santa Cruz Biotechnology (Santa Cruz,  CA). Rabbit anti- 
phosphatidylinositol  3-kinase (PI3K) serum, biotinylated anti-PY 
mAb, 4G10, and mouse anti-PLC-',/1 mAb were purchased from 
Upstate Biotechnology, Inc. (Lake Placid, NY). Goat anti-mouse 
IgM F(ab')2, goat anti-human lgM F(ab')2, and normal goat IgG 
F(ab')2 were purchased from Jackson Immunotkesearch Labora- 
tories,  Inc.  (West  Grove,  PA).  Rat  anti-mouse  CD22  mAb, 
NIM-tL6 (37), and rabbit anti-human CD22 serum raised against 
a peptide corresponding to the cytoplasmic  tail of human CD22 
(14) have been described.  Human PTP-1C was overexpressed  in 
293  cells by using an adenovirus  expression  system,  purified to 
homogeneity, and used as the immunogen for the generation of 
the rabbit  anti-PTP-1C serum (38). Anti-HA1 mAb 12CA5 was 
obtained from Berkeley Antibody Co. (Richmond, CA). 
Plasmid Constructs.  The  full-length  cDNA encoding human 
PTP-1C (PTP-1C  wT) (20) was cloned into the expression vector 
pILc/CMV (Invitrogen, San Diego, CA). Site-directed mutagen- 
esis of the full-length PTP-1C  cDNA replacing  Cys455 in the 
phosphatase  domain by a Ser yielded the null mutant (PTP-1CM). 
A  maltose-binding protein  (MBP)  fusion protein  plasmid  con- 
taining the double SH2 domains of PTP-1C has been described 
(20). To express an MBP fusion protein containing the NH2-ter- 
minal SH2 domain of PTP-1C, an EcoIkI/SpeI fragment con- 
taining the first 109 amino acids of PTP-1C was used to replace 
the double SH2 domain of this plasmid. For the generation of the 
CO OH-terminal SH2 domain of PTP-1C, a fragment of cDNA 
encoding the COOH-termianl SH2 domain of PTP-1C was am- 
plified  using a full-length cDNA clone of PTP-1C as the tem- 
plate  and the following primers:  5' primer,  5' GCG GGA TCC 
GAT CCC ACT AGT GAG AGG 3' and 3' primer,  5' GCG 
AAG CTT CTA CGG CTG CCG CAG GTA GAC 3'. The 
underlined nucleotides represent  BamHI and HindlII sites in the 
5' and 3' primers,  respectively.  The PCtL product was then cut 
with these enzymes and ligated into BamHI/HindlII-cut pMAL-c2 
(New England Biolabs, Beverly,  MA). 
For the generation  of glutathione  S-transferase  (GST)  fusion 
proteins containing the SH2 domains of Syk, PCR was used  to 
amplify cDNAs encoding either one or both SH2 domains of Syk 
using phSyk-1  (39) as template  and the following primer pairs: 
GST-SykSH2(N): 5' primer,  5'  GCG GGA TCC AGC GCC 
AAC CAC CR_G CCC 3'; 3' primer, 5' GCG GAA TTC CTT 
GGG CCG GTT GAA GGG 3'; GST-SykSH2(C): 5' primer, 5' 
GCG  GGA TCC  GAT  GAA AAA ATG  CCT  TGG  3';  3' 
primer, 5' GCG GAA TTC TCA GCC GAT TTT TTG ACA 
TGG  3';  GST-SykSH2(NC): 5'  primer,  5'  GCG  GGA TCC 
AGC GCC AAC CAC CtLG CCC 3'; 3' primer, 5' GCG GAA 
TTC TCA GCC GAT TTT TTG ACA TGG 3'. Underlined 
nucleotides represent  BamHI and EcoRI sites in the  5' and 3' 
primers,  respectively.  PCtL  products  were  cut  with  these  en- 
zymes and ligated into BamHI/EcoRI cut pGEX-2T (Pharmacia 
LKB Biotechnology, Inc., Piscataway, NJ). 
Plasmids encoding GST fusion proteins containing either one 
or both SH2 domains of PLC-~/1 have been described (11). All fu- 
sion protein constructs  were transformed  into Escherichia coli strain 
BL21(DE3) for protein production. 
The full-length mCD22 cDNA clone, pmCD22-4, has been 
reported (35). To detect transiently expressed mCD22 by Western 
blot analysis, mCD22 was epitope tagged with the influenza  he- 
magglutinin peptide  HA1  (40). The complete coding region of 
mCD22, without the stop  codon, was amplified  by PCR using 
the  template  pmCD22-4,  a  5'  primer  of 5'  GAT CGG ATC 
CGC GGC CTG GGA GAG AAA TAG CAG 3', and a 3' primer 
of 5' GCG GAA TTC GTG CTT GAG GGT CAC ATA GTC 
3'.  The  PCIL product was  cut with BamHI and EcoRI. The 
purified PCIL product was then ligated  in-frame with a double- 
stranded  oligonucleotide containing the HA1  sequence with  a 
5' EcoRI overhang, a 3' stop  codon, and a 3' XhoI overhang, 
and cloned into BamHl/Xho-cut pcDNA3 (Invitrogen). 
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to  transiently express  cDNAs in COS  cells. Briefly,  COS  cells 
were seeded  at -'~3 ￿  106 cells per  150-ram plate  16 h  before 
transfection.  Cells were washed twice with serum-free DMEM 
before transfection medium containing 400 p,g/ml DEAE-dex- 
tran, 0.1 mM chloroquine, and 3 p-g/ml each of the cDNA con- 
structs was added.  After a 3-4-h incubation at 37~  cells were 
pulsed with 10% DMSO in PBS at room temperature for 2 min 
and then returned to full medium. After 24 h, the medium was 
replaced with fresh DMEM containing 5% FCS.  Cells were ana- 
lyzed 72 h after transfection. 
B Cell Stimulation.  Daudi cells were pelleted and resuspended 
at  10  ￿  106/ml  in fully supplemented RPMI  1640.  Cells were 
equilibrated at 37~  for 10-15 min and then stimulated by F(ab')2 
fragments  of goat anti-human IgM (final concentration 10 p-g/ 
ml) or a mixture of H202 (2.5 rnM) and sodium orthovanadate 
(100 p,M) (referred to as peroxyvanadate). Controls  for F(ab')2 frag- 
ments of goat anti-human IgM were either F(ab')2 fragments  of 
normal goat IgG or F(ab')2 fragments  of goat anti-mouse IgM, 
and the control for peroxyvanadate was medium only. Stimula- 
tion was stopped at various time points by dilution of the cell sus- 
pensions into >10 vol of ice-cold PBS containing 0.02% NaN  3. 
Cells were pelleted and washed again with ice-cold PBS before 
lysis in 0.5% NP-40 buffer (see below). 
Subcellular Fractionation.  Cells were resuspended  at 20 ￿  106/ 
ml in PBS containing 1.5 mM MgC12, 1 mM EGTA, protease in- 
hibitors (2 mM PMSF, 10 p-g/ml aprotinin, 10 p-g/ml leupeptin, 
1 p-g/ml pepstatin, 100 Ixg/ml soybean trypsin inhibitor), and phos- 
phatase  inhibitors (10  mM  NaF,  1 mM  Na3VO4, and  5  mM 
Na4P207).  Cells were disrupted by nitrogen cavitation, 350 psi 
for 20 rain at 4~  The nuclei were isolated by centrifugation at 
1,000 g  for 20 rain. Postnuclear supernatants were then centri- 
fuged at 100,000 g for 45 min. Supernatants  after this spin ($100) 
were considered to represent the cytosolic  fraction.  The pellets 
(P100)  containing cell  organelles  and  plasma  membrane were 
washed once in PBS containing  protease inhibitors and then solu- 
bilized for 30 min at 4~  in 0.5% NP-40 lysis buffer containing 
150 mM NaC1, 50 mM Tris, pH 8.0, 5 mM EDTA plus protease 
and phosphatase  inhibitors as  described  above.  Debris was  re- 
moved by centrifugation at 14,000 g for 30 rain. The supernatants 
constituted the solubilized P100 fraction used for protein immu- 
noprecipitation. 
Immunoprecipitation  and  Western  Blotting.  Immunoprecipita- 
tion, SDS-PAGE, and Western blotting were conducted as de- 
scribed  (41). Binding of primary antibodies to blots was detected 
with  either horseradish  peroxidase-conjugated goat  anti-rabbit 
IgG (Jackson ImmunoResearch Laboratories,  Inc.) or horseradish 
peroxidase-conjugated  goat  anti-mouse  IgG  (Jackson  Immu- 
noResearch Laboratories,  Inc.) and an enhanced chemilumines- 
cence kit (Amersham Corp., Arlington Heights, IL). In Western 
blotting using fusion proteins, blots were incubated with 200 nM 
of fusion proteins in Tris-buffered saline (10 mM Tris,  pH 8.0, 
150 mM NaC1) with 0.01% Tween 20 and 5% BSA for 2 h  at 
room temperature. Binding of GST and MBP fusion protein was 
detected by a monoclonal anti-GST (Santa Cruz Biotechnology) 
or a rabbit anti-MBP serum (New England Biolabs) plus the ap- 
propriate horseradish-conjugated second-step goat antibody and 
enhanced chemiluminescence. 
Results 
Cross-Linking of the BCR Induces Recruitment of PTP-1C to 
the Particulate Fraction of B  Cells.  To  understand  the  po- 
tential function of PTP-1C in regulating BCR-mediated 
signal transduction, we examined the effect of cross-linking 
the BCR on the subcellular localization of PTP-1C. Rest- 
ing and activated B cells were fractionated into $100 (cyto- 
solic) and detergent solubilized P100 (membrane) fractions. 
The presence of cytosol-associated Csk  only in the  cyto- 
solic  fraction  and  membrane-associated Lyn  only  in  the 
membrane fraction confirmed the purity of the subcellular 
fractions obtained (Fig.  1 A). The majority of PTP-1C re- 
Figure 1.  Anti-IgM-induced recruitment of PTP-1C to the detergent-solubilizable  particulate fraction (Pl00). Daudi B cells were stimulated  with 
goat anti-human IgM F(ab')2 (10 ~g/ml) for the indicated lengths of time. Stimulation  was terminated by dilution of cell suspensions  into >10 vol of 
ice-cold PBS. Particulate (Pl00) and cytosolic ($100) fractions  were isolated as described in Materials and Methods. The P100 fraction  was then solubi- 
lized with 0.5% NP-40 lysis buffer (membrane). The purity of these fractions was determined by immunoblotting  for Csk, a cytosol-associated  PTK, and 
Lyn, a membrane-associated  PTK (A). PTP-IC was immunoprecipitated  from the cytosolic  and membrane fractions, resolved by reducing SDS-PAGE, 
and immunoblotted with anti-PTP-lC (B, left). The arrow indicates  the mobility  ofPTP-lC. A duplicate  blot ofPTP-1C immunoprecipitates  obtained 
from the membrane fraction  was also probed with the anti-PY mAb 4G10 (B, anti-PYblot, right). Arrows indicate the mobilities  of the 64- and 140-150- 
kD phosphoproteins. Negative control was immunoprecipitation  using normal rabbit serum (NRS) and unstimulated  B cell lysates. 
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l~). Detectable, albeit relatively limited, amounts of PTP-1C 
were also found associated with the membrane.  Stimulation 
of the BCR  with anti-human  lgM induced a rapid recruit- 
ment  of additional  PTP-1C  to  the  membrane  detectable 
within 20 s; this increased level remained steady for at least 
10 man of stimulation. Anti-PY blot of the PTP-1C  immu- 
noprecipitates  (IP)  from  the  membrane  fractions  revealed 
the presence  of two  groups  of proteins,  '~140--150  and 64 
kD, specifically phosphorylated  on tyrosine  (Fig.  1 B, right). 
Cross-Linking the BCR and CD22 Induces a Specific Interac- 
tion  between  PTP-1C and CD22.  Stimulation  of the  BCR 
induces a rapid tyrosyl phosphorylation  of CD22  (140-150 
kD)  (12,  13).  Therefore,  we  examined  whether  the  140- 
150-kD  protein coimmunoprecipitating with PTP-tC  was 
indeed CD22.  Anti-PY blotting of CD22  IP showed a low 
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Figure 2.  Anti-IgM- and anti-CD22-induced asso- 
ciation between PTP-1C and CD22 in B cells. Daudi 
B  cells were  stimulated  with  goat  anti-human  IgM 
F(ab')2 (10  p.g/ml)  for the indicated  lengths  of time, 
lysed in  NP-40 lysis buffer,  and  immunoprecipitated 
with the CD22 mAb HD39 (A), an anti-PTP-1C se- 
rum (B), or the CD19 mAb HD37 (C). IgGl control 
myeloma  protein  (MOPC)  or  normal  rabbit  serum 
(NRS)  was used  as  control for HD39  and  HD37  or 
anti-PTP-1C, respectively. IPs were resolved by SDS- 
PAGE  on  replicate  gels and  Western  blotted  onto 
membranes.  Membranes  containing  CD22  and  PTP- 
1C IPs were probed with an anti-CD22 serum, 4G10 
(anti-PY), or an anti-PTP-lC serum. Membranes con- 
taining CD19 IP were probed  with 4G10 (anti-PY), an 
anti-PI3K  serum,  or an  anti-PTP-1C  serum.  Arrows 
show the mobility of the indicated proteins.  (D) Daudi 
B  cells were  stimulated  by  10  /.tg/ml  of anti-CD22 
HD39.  CD22  was  immunoprecipitated  from  NP-40 
lysates using HD39, resolved by SDS-PAGE on repli- 
cate  gels,  and  immunoblotted  with  either  an  anti- 
CD22 serum,  4G10 (anti-PY), or an anti-PTP-1C se- 
rum.  Controls  were unstimulated  B cell lysates immu- 
noprecipitated  with MOPC. basal  level of tyrosyl phosphorylation before stimulation. 
Upon  BCtk  stimulation,  CD22  became  heavily  tyrosyl 
phosphorylated and associated with a 72-kD phosphopro- 
tein (Fig. 2 A, middle). Probing of the replicate blots with a 
rabbit  anti-PTP-1C  serum  showed  that  the  enzyme was 
induced  to  interact  with  CD22  (Fig.  2  A,  right). Con- 
versely, when PTP-1C was immunoprecipitated from the 
same  cells,  anti-PY  blot revealed the  presence of a  140- 
150-kD phosphoprotein that could be recognized by anti- 
CD22,  confirming the BCR-induced interaction between 
CD22  and PTP-1C  (Fig.  2  B,  middle and  right). CD19  is 
another  B  cell  accessory  molecule  that  becomes  tyrosyl 
phosphorylated and associates  with PI3K upon BCtk stim- 
ulation (42, 43, and Fig. 2 C, left  and middle); no association 
between CD19 and PTP-1C could be detected after BCtk 
ligation (Fig.  2  C, right), suggesting that the BCR-induced 
association  between  CD22  and  PTP-1C  was  specific. 
Moreover, cross-linking of CD22 alone on Daudi cells also 
induced tyrosyl phosphorylation of CD22 and the recruit- 
ment of PTP-1C to CD22 (Fig. 2 D). 
The NH2-terminal SH2 Domain of PTP-1C Mediates  Di- 
rect Interaction  between PTP-1C  and  Tyrosylophosphorylated 
CD22.  We next examined if  the SH2 domains of  PTP-1C 
could bind  to  tyrosyl-phosphorylated CD22.  Daudi  cells 
were stimulated with either goat anti-human IgM or per- 
oxyvanadate, which has been shown to elicit proximal sig- 
nal  transduction  events  in  lymphocytes  similar  to  those 
elicited by the Ag receptors  (44,  45).  The NH2-terminal 
SH2 domain (MBP-1CSH2[N])  and the double SH2 do- 
mains  (MBP-1CSH2[NC]), but not the COOH-terminal 
SH2 domain (MBP-1CSH2[C]), of  PTP-1C specifically pre- 
cipitated tyrosyl-phosphorylated 140-150-kD proteins from 
either anti-IgM-  or peroxyvanadate-activated Daudi  cells 
(Fig.  3 A, left). Western blotting with an anti-CD22 serum 
identified the 140-150-kD phosphoprotein precipitated by 
MBP-1CSH2(NC) as CD22  (Fig.  3 A,  right). When these 
fusion proteins were used to probe Western blots contain- 
ing CD22, both MBP-1CSH2(N) and MBP-1CSH2(NC) 
bound to tyrosyl-phosphorylated CD22 isolated from Daudi 
cells  after  anti-IgM  stimulation  (Fig.  3  B).  By  contrast, 
MBP-1CSH2(C)  did not bind to CD22  isolated from ei- 
ther  resting  or  anti-IgM-stimulated  B  cells.  Hence,  the 
NH2-terminal SH2 domain of PTP-1C apparently is essen- 
tial for CD22  binding.  Although  MBP-1CSH2(N)  could 
detect  tyrosyl-phosphorylated  CD22  on  Western  blot, 
CD22  was  not detected in  the MBP-1CSH2(N)  precipi- 
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Figure 3.  The NH2-terminal SH2 domain of 
PTP-1C  mediates  direct  interaction  between 
PTP-1C and tyrosyl-phosphorylated CD22,  (A) 
Daudi B  cells were stimulated with goat anti- 
human IgM F(ab')2 (g ol-hlgM)  (10  p~g/ml)  or 
hydrogen  peroxide  (2.5  rnM)  plus  sodium 
orthovanadate (100  p,M) (H202  +  VO43-) for 
5 min. Control cells were stimulated with nor- 
mal  goat  IgG  F(ab')2  (glgG)  (10  p~g/ml)  or 
medium alone. NP-40 cell lysates were precipi- 
tated  with  either  MBP-1CSH2(N),  MBP- 
1CSH2(C),  MBP-1CSH2(NC),  or  MBP  plus 
amylose-agarose. Bound proteins were resolved 
by SDS-PAGE on duplicate gels and immuno- 
blotted with either 4G10 (anti-PY)  (left) or anti- 
CD22 serum (right).  Arrows indicate either the 
mobility of a 140-150-kD phosphoprotein rec- 
ognized by the SH2 domains of PTP-1C  (left) 
or that of CD22  (right).  Proteins of 40, 44, 50, 
55, 69, and 102 kD are MBP, MBP fusion pro- 
teins,  or their degradation products  (dots).  (B) 
CD22  IP obtained from unstimulated or anti- 
IgM-stimulated Daudi  cells  were  resolved by 
SDS-PAGE on replicate gels and immunoblot- 
ted with either anti-CD22  serum,  4G10  (anti- 
PY),  MBP-1CSH2(N),  MBP-1CSH2(C),  or 
MBP-ICSH2(NC). Blotting with MBP did not 
detect any specific protein (data not shown). Figure 4.  In vivo complexes of CD22/PTP-1C/Syk 
and CD22/PTP-1C/Syk/PLC-~/1.  Daudi B cells were 
stimulated with either goat anti-hlgM  (A) or peroxy- 
vanadate (/3) as described in Fig. 3. CD22 was immu- 
noprecipitated from NP-40 lysates, resolved by SDS- 
PAGE on replicate gels, and immunoblotted with the 
indicated antibodies. Arrows indicate the mobilities of 
proteins detected by the different antibodies. 
tates. It is possible that MBP-1CSH2(N)  precipitated a very 
small  amount  of  highly  tyrosyl-phosphorylated  CD22, 
which the anti-CD22  serum used could not detect. 
In  Vivo Complex of CD22,  PTP-1C,  Syk,  and PLC-T1. 
Since  CD22  was the  major membrane protein  with  which 
PTP-1C  could interact upon BCR  stimulation  of Daudi B 
cells  (Figs.  1-3),  we  hypothesized  that  this  recruitment 
might be a  way by which  B  cells  could  direct  PTP-1C  to 
its  substrate(s),  particularly  phosphoproteins  associating 
with  CD22.  Low  basal  levels  of tyrosyl  phosphorylation 
were detected  on CD22  isolated from unstimulated  Daudi 
cells,  whereas  heavily  tyrosyl-phosphorylated  proteins  of 
130-150  and  72  kD  were  detected  after  either  anti-slgM 
(Figs.  2  A  and  4  B)  or peroxyvanadate  (Fig.  4  A)  stimula- 
tion.  Probing  of replicate  blots  with  anti-Syk  serum  re- 
vealed that the  72-kD  protein was Syk; a  small amount  of 
unphosphorylated  Syk  was  also  associated  with  CD22  in 
unstimulated  cells. PLC-yl  was detected  in CD22  IP from 
peroxyvanadate-stimulated cells and comigrated with CD22 
(Fig.  4  A), but not from anti-slgM-stimulated  cells  (Fig.  4 
B).  PTP-1C  was detected in the CD22  IP from stimulated 
cells,  as  shown  in  Figs.  1-3.  The  absence  of detectable 
PLC-~/1  in  anti-IgM-stimulated  cells might be  due  to  the 
stronger  stimulation  delivered  by peroxyvanadate.  Collec- 
tively, stimulation of B  cells through their antigen receptors 
or  using peroxyvanadate  could  indeed  induce  the  in  vivo 
formation of complexes consisting of either CD22/PTP-1C/ 
Syk or CD22/PTP-1C/Syk/PLC-"/1. 
The COOH-terminal  SH2 Domain of Syk Binds Directly to 
Tyrosyl-phosphorylated CD22.  The  molecular basis for the 
interaction between Syk and CD22 was examined using GST 
fusion proteins containing either one or both SH2 domains 
ofSyk. A  140-150-kD  tyrosyl-phosphorylated protein was 
the  major protein  that  GST-SykSH2(C)  or  (NC)  precipi- 
tated  from  either  anti-slgM-  or  peroxyvanadate-activated 
B cells (Fig. 5 A, left). The NH2-terminal SH2 domain of Syk 
also  weakly  precipitated  a  140-150-kD  phosphoprotein 
from peroxyvanadate-stimulated  Daudi cells (Fig. 5 A,  left). 
Western blotting of the fusion protein precipitates obtained 
from lysates ofperoxyvanadate- (Fig.  5 A, right) or anti-slgM- 
(data  not  shown)  activated B  cells with  an  anti-CD22  se- 
rum revealed that GST-SykSH2(C)  or GST-SykSH2(NC) 
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mains of Syk mediate a direct interaction 
between  Syk  and  tyrosyl-phosphorylated 
CD22. Daudi B cells were stimulated as de- 
scribed for Fig. 3. NP-40  cell lysates were 
precipitated  with  either  GST,  GST- 
SykSH2(N),  GST-SykSH2(C),  or  GST- 
SykSH2(NC)  plus  glutathione-agarose. 
Bound  proteins  were  resolved by  SDS- 
PAGE on duplicate gels and immunoblot- 
ted with either 4G10 (anti-PY) (left) or anti- 
CD22 serum (right). Arrows indicate either 
the mobility of a 140-150-kD phosphopro- 
tein recognized by the SH2 domains of Syk 
(left) or that of CD22 (right).  Low molecular 
mass proteins of 26-50 kD are GST, GST- 
SykSH2 fusion proteins, or their degrada- 
tion products (dots). (13) CD22 IP obtained 
from unsfimulated or anti-IgM--stimulated 
Daudi cells were resolved by SDS-PAGE 
on replicate gels and immunoblotted with 
either anti-CD22 serum, 4GI0 (anti-PY),  or 
GST-SykSH2(NC). Blotting with GST did 
not  detect any  specific protein (data not 
shown). 
could precipitate  CD22.  Western  blotting  using the  GST 
SH2 fusion proteins showed GST-SykSH2(NC)  could bind 
directly to tyrosyl-phosphorylated CD22 isolated from anti- 
IgM-stimulated  Daudi  cells  (Fig.  5  B).  Taken  together, 
these results suggest that Syk can directly interact with tyrosyl- 
phosphorylated CD22 via its COOH-termmal SH2 domain. 
The NHe-terminal SH2 Domain of PLC-T1 Binds Directly to 
Tyrosfl-Phosphorflated CD22.  The SH2 domains of PLC-~/1 
can bind to Syk (10,  11). We have located the Syk-binding 
region  of PLC-~/1  to its  SH2(C)  domain  (11).  In addition 
to Syk, the individual SH2 domains of  PLC-~/1 also precip- 
itated  a  number  of tyrosyl-phosphorylated proteins  from 
stimulated B cell lysates (Fig. 6 A, lg0). Thus, GST-ylSH2(N) 
precipitated  tyrosyl-phosphorylated  proteins  of  140,  59, 
and  52  kD,  whereas  GST-"/1SH2(C)  precipitated  tyrosyl- 
phosphorylated  proteins  of 84,  72,  59,  and  52  kD.  The 
double  (NC)  SH2  domains  precipitated  a  combination  of 
the  proteins  recognized  by  the  individual  SH2  domains. 
Sequential  Western  blotting  of these  precipitates  with  an 
anti-Syk followed by an anti-CD22 serum showed that, in- 
deed, the 72-kD protein was Syk whereas the 140 kD pro- 
tein was CD22  (Fig. 6 A, right). Although other undefined 
tyrosyl-phosphorylated proteins also coprecipitated,  the in- 
teraction between the SH2(N) of PLC-yl was probably di- 
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rect, since GST-~/1SH2(NC)  could bind directly to tyrosyl- 
phosphorylated  CD22  isolated  from  anti-IgM--stimulated 
Daudi cells on Western blots (Fig. 6/3). 
Cotransfection  of  CD22  with  PTP-1C  M,  but  Not  PTP- 
1C  wr, in COS Cells Results in the Formation of a Stable Com- 
plex between CD22 and PTP-1C  u.  The  complex  con- 
sisting of tyrosyl-phosphorylated CD22,  Syk, and PLC-~/1 
with  PTP-1C  in stimulated  B  cells  (Fig.  4)  suggested that 
PTP-1C might use one or more of  these phosphoproteins as 
substrates.  In an attempt  to study the  interaction  between 
CD22 and PTP-1C, we transfected COS cells with a cDNA 
encoding  a  null  mutant  PTP-1C  (PTP-lC M)  that  lacked 
phosphatase  activity  and  a  cDNA  encoding  mCD22.  To 
facilitate the detection  of mCD22 by Western blotting,  an 
HA  tag  was  added  in-frame  before  the  stop  codon  of 
mCD22  (mCD22HA).  mCD22HA was not tyrosyl phos- 
phorylated when  transfected  alone  (Fig.  7  A).  Cotransfec- 
tion of mCD22HA with PTP-1C  M resulted in an associa- 
tion between the two, accompanied by a dramatic increase 
in tyrosyl phosphorylation of mCD22HA (Fig. 7 A, middle 
and  bottom; Fig.  7  B,  top and  middle). On the  other hand, 
PTP-1C  associating  with  mCD22HA  was  not  tyrosine 
phosphorylated, indicating that the enzyme need not be ac- 
tive  or  tyrosyl phosphorylated  to  bind  to  mCD22HA  in Figur#  6.  The  NHz-terminal  SH2  do- 
main of PLC-~/I mediates a direct interac- 
tion  between  PLC-"/1 and  tyrosyl-phos- 
phorylated  CD22.  Daudi  B  cells were 
stimulated as described for  Fig. 3.  NP-40 
cell lysates were  precipitated  with  either 
GST-'y1SH2(N),  GST-ylSH2(C),  GST- 
ylSH2(NC), or GST plus glutathione-aga- 
rose.  Bound  proteins  were  resolved  by 
SDS-PAGE on duplicate gels and immuno- 
blotted with  either 4G10 (anti-Pg) (left) or 
anti-CD22  serum  plus anti-Syk  serum 
(tight). Arrows indicate either the mobilities 
of phosphoproteins recognized by the SH2 
domains of PLC-~/1 (left), CD22  (right), or 
Syk (right). Low molecular mass proteins of 
35-48  kD  are  GST-PLC-ylSH2  fusion 
proteins or their degradation products (dots). 
(B) CD22 IP obtained from unstimulated or 
anti-IgM~timulated  Daudi  cells were  re- 
solved by SDS-PAGE on replicate gels and 
immunoblotted  with  either anti-CD22  se- 
rum, 4G10 (anti-PY), or GST-3'ISH2(NC). 
Blotting with GST did not detect any spe- 
cific protein (data not shown). 
vivo (Fig. 7, A  and B,  middle).  When increasing quantities 
of wild-type PTP-1C  (PTP-1C wT)  were  mixed with  de- 
creasing quantities of PTP-1C M and cotransfected with the 
mCD22HA,  both the  levels of tyrosyl phosphorylation in 
mCD22HA  and  the  association between  mCD22HA  and 
PTP-1C decreased in a dose-dependent manner. The amount 
of immunoprecipitable mCD22HA  and PTP-1C  (mixture 
of PTP-1C wT and PTP-1C M) were comparable in the dif- 
ferent  transfectants  (Fig.  7,  A,  top,  and  B,  bottom).  There- 
fore, the absence of the phosphatase activity in PTP-1C  fa- 
cilitated  the  association  of  PTP-1C  with  mCD22HA; 
expression of PTP-1C wT  alone with  mCD22HA  resulted 
in  low  levels  of mCD22HA  tyrosyl phosphorylation  and 
some  association with  mCD22HA.  Although  the  HA  tag 
contained several tyrosyl residues, it was unlikely that this 
association was due to these tyrosyl residues, because iden- 
tical  results  were  observed  using  the  native,  nontagged, 
mCD22  cDNA (data not shown). 
Overexpression  of Either PTPo 1C  M or PTP-1C  wr Does Not 
Alter the  Overall  Levels  of Tyrosyl  Phosphorylation  of Cellular 
Proteins in COS Cells.  The  tyrosyl  phosphorylation  of 
mCD22HA  and its association with PTP-1C M may be oc- 
curring because  (a)  endogenous  PTP  activities, including 
the low but detectable amount  of PTP-1C  (Fig. 7  t3,  bot- 
tom),  negatively regulate the overall PTK activities in COS 
ceils. In this  case,  transfection  of PTP-1C M would  domi- 
nantly suppress the activity of endogenous PTP-1C or other 
PTP  and release the PTKs from negative regulation, lead- 
ing in turn to an elevated tyrosyl phosphorylation of cellu- 
lar proteins including mCD22HA;  or alternatively (b)  cer- 
tain  PTKs  (e.g.,  Src-family kinases)  might  phosphorylate 
mCD22 constitutively, whereas endogenous PTP-1C would 
specifically dephosphorylate mCD22  to  reduce its level of 
tyrosyl phosphorylation. In this case, transfection ofPTP-1C M 
would  dominantly  suppress  the  activity  of  endogenous 
PTP-1C  (or related enzymes), thereby allowing mCD22HA 
to become hyperphosphorylated to interact with PTP-1C M. 
In  the  first instance,  transfection  of PTP-1C M should  in- 
crease the level of tyrosyl phosphorylation of other cellular 
proteins.  In  contrast,  in  the  second  case,  transfection  of 
PTP-1C M would have no  major effect on the level of ty- 
rosyl phosphorylation of cellular proteins other than CD22. 
To  distinguish between  these  two  possibilities, we  trans- 
fected COS  cells with  PTP-1CWT/pTP-IC M in  different 
proportions. The level of tyrosyl phosphorylation of cellu- 
lar proteins in general remained similar to the mock-trans- 
554  CD22-associating Proteins in B cells Figure 7.  Cotransfection of CD22 with PTP-1C  M  in COS cells results in the formation of a complex between CD22 and PTP-1C  M. COS cells were 
transiently transfected with mCD22HA cDNA (3 ~g/ml) and a mixture ofcDNAs (total of 3 ~g/ml) encoding for both the wild-type PTP-1C (PTP- 
1C  wT) and a phosphatase-negative variant (PTP-1C M) at the ratios indicated in the figure. Details of transfection and construction of cDNAs are de- 
scribed in Materials and Methods. 72 h after transfection, cells  were lysed in 0.5% NP-40 lysis  buffer, mCD22HA (A) and PTP-1C (B) were immunopre- 
cipitated, resolved by reducing SDS-PAGE on replicate gels, and immunoblotted with an anti-HA tag mAb, 4G10 (anti-PY), or an anti-PTP-1C serum. 
Control precipitations were done using MOPC or normal rabbit serum (NRS) with lysates  from COS cells transfected with 3 p~g/ml  ofmCD22HA and 
PTP- 1C  w'r cDNAs. 
fected cells, regardless of  the ratio ofPTP-1C wT to PTP-1C  M 
(Fig. 8).  These results support the view that in COS cells, 
CD22 might serve as a substrate for PTP-1C. 
Discussion 
In this report, we describe the association of  CD22 with key 
regulatory enzymes, including Syk, PLC-~/1,  and PTP-1C 
in B  lymphocytes. The fact that tyrosyl phosphorylation of 
Syk and PLC-~/1  correlates with their enzymatic activation 
suggests  that  PTP-1C  may  function  to  downregulate  the 
BCR-mediated  signal  transduction  cascade  by  catalyzing 
their dephosphorylation. 
The NH2-terminal SH2 domain of PTP-1C binds to ty- 
rosyl-phosphorylated CD22  (Fig. 3).  Since MBP-1CSH2(C) 
did  not  precipitate  any  detectable  tyrosyl-phosphorylated 
proteins from B  cell lysates, it is possible that the COOH- 
terminal  SH2  domain  of PTP-1C  alone  does  not  possess 
high  binding  affinity toward  phosphorylated  tyrosyl resi- 
dues.  Alternatively,  SH2(C)  of  PTP-1C  might  not  be 
folded to  its  optimal  conformation  when  expressed as  an 
MBP fusion protein by bacteria. However, the presence of 
SH2C  clearly increases the overall affinity of interaction as 
revealed by the increased quantity of CD22 precipitated by 
MBP-1CSH2(NC)  versus  MBP-1CSH2(N),  and  also  the 
elevated  binding  obtained  when  MBP-1CSH2(NC)  was 
used for Western blotting of CD22  (Fig. 3  B).  Taken  to- 
gether,  our results confirm and  extend  recently published 
555  Law et al. Figure 8.  Expression of either PTP-1C wT or PTP-1C M  in COS cells 
does not alter tyrosyl  phosphorylation  of  cellular proteins. COS cells were 
transfected with a mixture of cDNAs (total of  3 ~g/ml) at the ratios indi- 
cated in the figure. 72 h after transfection, cells were lysed in 0.5% NP-40 
lysis buffer. Cellular tyrosyl-phosphorylated  proteins and PTP-1C  were 
immunoprecipitated by PY20 (anti-PY)  and an anti-PTP-1C  serum, re- 
spectively, resolved by reducing SDS-PAGE, and Western blotted. The 
level of tyrosyl phosphorylation on cellular proteins was determined by 
blotting with 4G10, and the expression of PTP-1C  was determined by 
blotting with an anti-PTP-1C serum. 
findings using mouse B  cells  (34,  35).  SH2(N)  of PTP-1C 
also  mediates  the  interactions  between  PTP-1C  and  c-kit 
(30)  or the EPO-1  receptor  (27).  On the  other hand,  the 
specificity of the binding of PTP-1C to the Fo/IIB recep- 
tor is  determined  by its  SH2(C)  domain  (33).  In all  cases, 
the presence  of the  second SH2  domain  considerably im- 
proves  the  overall  ability  of PTP-1C  to  interact  with  its 
ligands. 
The interaction between  CD22 and PTP-1C may serve 
multiple functions. First, the SH2 domains of PTP-1C have 
been shown to inhibit its phosphatase  activity, presumably 
via  an  intramolecular  interaction  (46,  47);  binding  of the 
SH2(N)  domain  to  CD22  may  release  this  inhibition.  In 
fact,  synthetic  phosphopeptides  corresponding to  the  im- 
munoreceptor  tyrosine-based  inhibitory  motifs  (ITIM)  of 
both Fc~/IIB (33)  and CD22  (35)  increase the phosphatase 
activity of PTP-1C. Second, anionic phospholipids are po- 
tent  activators  of this  enzyme  (48);  therefore,  relocating 
PTP-1C to the plasma membrane may provide a rich source 
of anionic phospholipids to enhance its activity. Third,  our 
data show that in addition to PTP-1C, both Syk and PLC-'y1 
can  physically interact  with  CD22  (Figs.  4-6),  and  com- 
plexes  of  CD22/PTP-1C/Syk  or  CD22/PTP-1C/Syk/ 
PLC-~/1 assemble in stimulated B  cells (Fig. 4).  Hence, the 
interaction  between  CD22  and  PTP-1C  may juxtapose 
PTP-1C to its substrates,  including CD22, Syk, and PLC-',/1. 
Fourth, the anti-CD22-induced tyrosyl phosphorylation of 
CD22 and recruitment of PTP-1C  (Fig. 2  D)  may seques- 
ter the phosphatase from other signal transduction pathways. 
This is supported by the earlier findings that anti-CD22 can 
potentiate  the  increase  in  [Ca2+]i and B  cell proliferation 
induced by anti-IgM (16,  17). 
Doody et al.  (35) have identified pY783AIL, pY843SEL, 
and pY863VTL to be  three  PTP-1C-binding  sites  in  the 
cytoplasmic tail of mouse CD22. Despite the relatively low 
overall  sequence  identity between  the  cytoplasmic tails  of 
mouse and human CD22  (65%),  all six tyrosyl residues  are 
conserved  between  human  and  mouse  (37)  and  the  two 
known mCD22 alleles  (49). Therefore, it is very likely that 
the corresponding tyrosyl residues in the cytoplasmic tail of 
human CD22 are the targets for human PTP-1C.  Our ob- 
servation that human PTP-1C  M can bind to mouse CD22 
in COS cells  supports this possibility (Fig. 7). 
Syk associates with the BCR in both mouse (50) and hu- 
man  (14,  39)  B  cells.  However,  the  exact  nature  of this 
interaction is not clear.  In this study, we have provided ev- 
idence  that  the  COOH-termmal  SH2  domain  of Syk  can 
specifically precipitate  and immunoblot tyrosyl-phosphory- 
CD22 
cross-linking slgM 
of CD22 (Lyn?) 
IP3 
N~C 
N~c 
?~-- 
Figure  9.  A model for the interaction between CD22, 
Syk, PLC-~/1, and PTP-1C.  After BCP,. ligation, CD22 is 
tyrosyl  phosphorylated  and thereby serves as a membrane an- 
chor for Syk, PLC-3d, and PTP-1C. 
556  CD22-associating  Proteins in B cells lated  CD22  obtained from either  anti-slgM-  or peroxy- 
vanadate-stimulated B cells (Fig.  5). Similar to the SH2(C) 
domain of PTP-1C, the SH2(N) domain of Syk may not 
possess high binding affinity toward phosphorylated tyrosyl 
residues, or it may not fold to its optimal conformation for 
ligand recognition when expressed as a bacterial GST fu- 
sion  protein.  Nevertheless,  the  association  between  the 
SH2(N) domain of Syk and CD22 may provide a physical 
link between Syk and the BCP,..  It is also possible that Syk 
may interact directly with the Iga/Igl3 heterodimer, since 
this  association has been found to  occur under detergent 
conditions in which CD22 is dissociated from the Iget/Ig[3 
complex (50; Law, C.-L., K.A. Chandran,  S.P. Sidorenko, 
and E.A. Clark, manuscript in preparation). 
The interaction between PLC-~/1 and CD22 is mediated 
directly by the NH2-terminal SH2 domain of PLC-yl (Fig. 
6). The COOH-terminal domain, on the other hand, me- 
diates the binding of  PLC-~/1 to tyrosyl-phosphorylated Syk 
(Fig.  6 A)  (11).  The function of this latter interaction was 
revealed by the finding that Syk can phosphorylate a key 
regulatory tyrosyl residue, Y783, in PLC-~/1 in vitro (11). 
However, when  an  enzymatically active mCD8-Syk chi- 
mera is expressed in COS  cells,  the basal  [Ca2+]i  of these 
cells  remains the same  as mock transfectants  (Law,  C.-L., 
K.A. Chandran, and E.A. Clark, unpublished observations). 
This suggests  that additional factors are needed to permit 
the ettqcient hydrolysis ofphosphoinositides. Therefore, the 
presence  of  tyrosyl-phosphorylated  cytoplasmic  tails  of 
CD22 to which both Syk and PLC-yl can bind during B 
cell activation may provide the essential  scaffolding needed 
for (a) eflqcient tyrosyl phosphorylation of PLC-',/1 by Syk 
and  (b)  to  localize  and  stabilize  tyrosyl-phosphorylated 
PLC-'y1 in the plasma  membrane, where its phosphoinosi- 
tide substrates  are present. 
It is still unknown which tyrosyl residues in the cytoplas- 
mic tail of CD22  are recognized by the  SH2 domains of 
Syk or PLC-yl. Since PTP-1C binds to pY783, 843, and 
863 (35), Syk and PLC-~/1 may bind to other tyrosyl resi- 
dues by analogy to the EPO-1 receptor, which has distinct 
domains for JAK2 and PTP-1C binding (27). Based on the 
prediction  by  Songyang  et  al.  (51,  52),  Y817SVI  and 
Y828ENV in CD22 are potential sites for Syk and PLC-yl 
binding, respectively. It is also possible that Syk, PLC-~I, 
and PTP-1C may compete for the same site(s) in the cyto- 
plasmic tail of CD22. Experiments are now in progress to 
assess these possibilities. 
We (14) and others (15) have proposed that one or more 
of the tyrosyl residues of CD22 display  the consensus mo- 
tifs characteristic of immunoreceptor tyrosine-based activa- 
tion motifs (ITAMs). The discovery that PTP-1C binds to 
phosphorylated CD22 suggests  that ITIMs could also exist 
in the cytoplasmic tail of CD22 (35). Taking into consider- 
ation the binding of both Syk and PLC-',/1 to phosphory- 
lated CD22, we propose that the cytoplasmic tail of CD22 
contains both ITAMs and ITIMs, which could play crucial 
roles in the regulation of PLC-~/1 activation. 
Two models can be proposed for the function of the in- 
teraction between CD22 with Syk, PLC-'y1, and PTP-1C. 
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In the first one (Fig. 9), activation of B cells induces a rapid 
phosphorylation of CD22  (most likely the  Src-family ki- 
nase Lyn); in turn,  the phosphotyrosyl residues generated 
provide docking sites for the SH2 domains of Syk, PLC-',/1, 
and PTP-1C. The interaction between these components 
may allow for the tyrosyl phosphorylation of PLC-~I  by 
Syk  (11),  thereby triggering  phosphoinositide  hydrolysis. 
On the other hand, the recruitment of PTP-1C may pro- 
vide a means to terminate the signal by the dephosphoryla- 
tion of either CD22,  Syk, and/or PLC-~/1,  analogous to 
the function of PTP-1C in the inactivation of EPO-1  re- 
ceptor-associated JAK2  (27).  Alternatively,  since  the  re- 
cruitment of PTP-1C  to  CD22  occurs within  20  s after 
BCP, cross-linking (Figs. 1 and 2) at a rate similar to the ac- 
tivation of Ag receptor-associated PTKs, including Syk (39) 
and Lyn (53; Law, C.-L., K.A. Chandran,  S.P.  Sidorenko, 
and E.A. Clark, manuscript in preparation), it is also possi- 
ble  that  individual  cytosolic  proteins  may  compete  for 
binding to CD22. In this case, the on- and off-rates of the 
various SH2 domains involved will become the determin- 
ing factors on how signal transduction by the BCR. is regu- 
lated by these CD22-binding proteins. 
To allow for the receptor-activated PTKs to propagate 
their signals  during BCR cross-linking, PTP-1C may not 
be fully active initially. Although both the COOH-termi- 
nal segment (38) and the SH2 domains (46, 47) of PTP-1C 
can negatively regulate its  activity, it is still not clear how 
PTP-1C activity is modulated in lymphocytes. The bind- 
ing of PTP-1C to  CD22  through its  NH2-terminal SH2 
domain, however, is likely to increase, rather than repress, 
its phosphatase activity. PTP-1C can be tyrosyl phosphory- 
lated by Src and Lck on Tyr538 (54, 55); tyrosyl phosphor- 
ylation of PTP-1C has been reported in CSF-1--stimulated 
macrophages  (31),  stem cell factor--stimulated Mo7e  cells 
(30),  and insulin-stimulated IM9 cells  (56).  Tyrosyl phos- 
phorylation of PTP-1C  (56)  and its  homologue PTP-2C 
(57) increases their phosphatase activities. Little, if any, ty- 
rosyl phosphorylation can be detected in the CD22-associ- 
ated PTP-1C after BCR. ligation (Figs. 2 and 4). It is possi- 
ble that at an early phase of B  cell activation when PTKs 
are active, PTP-1C remains dormant because it is not ty- 
rosyl phosphorylated. Experiments are now in progress to 
define the relationship between the activity of PTP-1C and 
its state of phosphorylation in B lymphocytes. 
What are the substrates  for PTP-1C? The data shown in 
Figs. 7 and 8 may shed some light on this question. Trans- 
fection  of different  ratios  of wild-type  to  null  mutated 
PTP-1C into COS cells did not affect the overall levels of 
tyrosyl phosphorylation of cellular proteins, whereas trans- 
fection of PTP-IC  M, but not PTP-1C  wT, brought about a 
high stoichiometry tyrosyl phosphorylation of mCD22HA 
and  increased  the  association  between  the  two  proteins. 
Both responses could be abolished by increasing the pro- 
portion  of PTP-1C  wT that  was  cotransfected with  PTP- 
1C  M.  These  data  suggest  that  phosphorylated CD22  is  a 
substrate for PTP-1C. The ability for PTP-1C to dephos- 
phorylate the same protein that it binds to is not unique to 
CD22, since PTP-1C has been shown to bind to and de- phosphorylate  the  IL-3  receptor  (29).  Functionally,  de- 
phosphorylation  of CD22  by  PTP-1C  may  result  in  the 
dissociation of the  CD22/Syk/PLC-y1  complex  and  the 
termination  of the  activation of PLC-yl.  This  would  be 
consistent with recent observations that Ag triggers a more 
elevated Ca  2+ flux in PTP-lC-deficient cells (36). 
We thank Drs. Stephen J. Klaus and Friederike Siebelt for their critical review of this manuscript. 
This work was supported by National Institutes of Health grants GM42508, GM37905, DK07902,  and the 
International Human Frontier Sciences Programs.  C.-L. Law is a Special Fellow of the Leukemia Society of 
America. S. Sidorenko is on leave from the Kavetsky Institute of Experimental Pathology, Oncology and 
Radiobiology, Ukrainian Academy of Sciences, Kiev, Ukraine. 
Address correspondence to Che-Leung Law, University of Washington, Department of Microbiology, Box 
357242,  Seattle, WA 98195-7242. 
Received for publication  14 August  1995 and in revised  form  17 October  1995. 
References 
l.  Cambier, J.C., C.M. Pleiman, and M.R. Clark. 1994.  Signal 
transduction by the B  cell antigen receptor and its corecep- 
tors. Annu.  Rev. Immunol.  12:457-486. 
2.  Pleiman,  C.M.,  D.  D'Ambrosio, and J.C.  Cambier.  1994. 
The  B-cell antigen  receptor complex:  structure  and  signal 
transduction. Immunol.  Today.  15:393-399. 
3. Justement, L.B., V.K. Brown, andJ. Lin. 1994. Regulation of 
B-cell activation by CD45: a question of mechanism. Immu- 
nol.  Today.  15:399-406. 
4.  Fearon,  D.T.,  and  R.H.  Carter.  1995.  The  CD19/CR2/ 
TAPA-1  complex of B  lymphocytes: linking natural to ac- 
quired immunity. Annu.  Rev. Immunot.  13:127-149. 
5.  Law, C.-L., S.P. Sidorenko, and E.A. Clark.  1994.  Regula- 
tion  of lymphocyte activation by the  cell-surface molecule 
CD22. lmmunol.  Today.  15:442-449. 
6.  Kolanus, W., C. Romero, and B. Seed. 1993.  T  cell activa- 
tion by clustered tyrosine kinases.  Cell.  74:171-183. 
7.  Rivera, V.M., andJ.S. Brugge. 1995. Clustering of Syk is suf- 
ficient to induce tyrosine phosphorylation and release of al- 
lergic mediators from rat basophilic leukemia cells. Mol.  Cell. 
Biol.  15:1582-1590. 
8.  Takata,  M.,  H.  Sabe,  A.  Hata,  T.  Inazu,  Y.  Homma,  T. 
Nukada, H. Yamamura, and T. Kurosaki. 1994. Tyrosine ki- 
nases Lyn and Syk regulate B cell receptor-coupled Ca  2+ mo- 
bilization through distinct pathways. EMBO  (Eur.  Mol.  Biol. 
Organ.)J.  13:1341-1349. 
9.  Sidorenko, S.P., C.L. Law, K.A. Chandran, and E.A. Clark. 
1995.  Human  spleen tyrosine kinase p72Syk associates  with 
the  Src-family kinase p53/56Lyn  and a  120-kDa phospho- 
protein. Proc. Natl. Acad.  Sci.  USA. 92:359-363. 
10. Sillman, A.L., andJ.G. Monroe. 1995.  Association ofp72syk 
with the src homology-2 (SH2) domains ofPLC-gamma 1 in 
B lymphocytes.  J. Biol.  Chem. 270:11806-11811. 
11. Law, C.-L., K.A. Chandran, S.P. Sidorenko, and E.A. Clark. 
1996.  Phospholipase  C-gamma  1  interacts  with  conserved 
phosphotyrosyl residues in the linker region of Syk and is a 
substrate for Syk. Mol.  Cell.  Biol.  In press. 
12. Powell,  L.D.,  and  A.  Varki.  1995.  l-type lectins. J.  Biol. 
Chem. 270:14243-14246. 
13. Schulte,  R.J.,  M.A.  Campbell,  W.H.  Fischer,  and  B.M. 
Sefton.  1992.  Tyrosine phosphorylation of CD22  during B 
558  CD22-associating Proteins 
cell activation. Science (Wash. DC). 258:1001-1004. 
14. Leprince, C., K.E. Draves, R.L. Geahlen, J.A. Ledbetter, and 
E.A.  Clark.  1993.  CD22  associates  with the human  surface 
IgM-B-cell antigen receptor complex. Proc. Natl.  Acad.  Sci. 
USA.  90:3236--3240. 
15. Peaker,  C.J.,  and  M.S.  Neuberger.  1993.  Association  of 
CD22 with the B  cell antigen receptor. Eur. J.  Immunol.  23: 
1358-1363. 
16. Pezzutto, A., B. D6rken,  G. Moldenhauer, and E.A. Clark. 
1987.  Amplification of human B  cell activation by a mono- 
clonal antibody to the B cell-specific antigen CD22, Bp 130/ 
140.J. Immunol.  138:98-103. 
17. Pezzutto, A., P.S. Rabinovitch, B. Dorken, G. Moldenhauer, 
and E.A. Clark. 1988.  Role of the CD22 human B cell anti- 
gen in B cell triggering by anti-immunoglobulin.  J. Immunol. 
140:1791-1795. 
18. Sun,  H., and N.K. Tonks.  1994.  The coordinated action of 
protein  tyrosine phosphatases  and  kinases in  cell signaling. 
Trends Biochem.  Sci.  19:480-485. 
19. Hunter,  T.  1995.  Protein kinases  and phosphatases: the yin 
and yang of protein phosphorylation and signaling. Cell.  80: 
225-236. 
20. Shen, S.H., L. Bastien, B.I. Posner, and P. Chr~tien. 1991. A 
protein-tyrosine phosphatase with sequence similarity to the 
SH2 domain of the protein-tyrosine kinases.  Nature  (Lond.). 
352:736-739. 
21. Matthews, 1k.J., D.B. Bowne, E.  Flores, and M.L. Thomas. 
1992.  Characterization of hematopoietic intracellular protein 
tyrosine phosphatases: description ofa phosphatase containing 
an SH2 domain and another enriched in proline-, glutamic 
acid-, serine-, and threonine-rich sequences. MoL  Cell.  Biol. 
12:2396-2405. 
22. Plutzky, J., B.C. Ned, and R.D. Rosenberg. 1992.  Isolation 
of a  src  homology 2-containing tyrosine phosphatase. Proc. 
Natl. Acad.  Sci.  USA.  89:1123-1127. 
23. Yi, T.L., J.L. Cleveland, andJ.N, lhle. 1992. Protein tyrosine 
phosphatase containing SH2 domains: characterization, pref- 
erential expression in hematopoietic cells, and localization to 
human chromosome 12p12-p13. Mol.  Cell.  Biol.  12:836-846. 
24. Shultz, L.D., P.A. Schweitzer, T.V. Rajan, T. Yi, J.N.  lhle, 
R.J. Matthews, M.L. Thomas, and D.R. Beier. 1993.  Muta- 
in Bce~s tions at the murine motheaten locus are within the hemato- 
poietic cell protein-tyrosine phosphatase (Hcph)  gene.  Cell. 
73:1445-1454. 
25. Tsui, H.W., K.A. Siminovitch, L. de Souza, and F.W. Tsui. 
1993.  Motheaten and viable motheaten mice have mutations 
in the haematopoietic cell phosphatase gene. Nat.  Genet.  4: 
124-129. 
26. Shultz, L.D., and C.L. Sidman. 1987.  Genetically determined 
murine models ofirnmunodeficiency. Annu.  Rev. Immunol. 5: 
367-403. 
27. Klingmuller, U.,  U.  Lorenz, L.C.  Cantley, B.G.  Neel,  and 
H.F. Lodish.  1995.  Specific recruitment of SH-PTP1  to the 
erythropoietin receptor causes inactivation of  JAK2 and ter- 
mination of  proliferative signals. Cell. 80:729-738. 
28. Yi, T., J. Zhang, O. Miura, andJ.N. Ihle. 1995.  Hematopoi- 
eric cell phosphatase associates with erythropoietin (Epo) re- 
ceptor after Epo-induced receptor tyrosine phosphorylation: 
identification of potential binding sites. Blood.  85:87-95. 
29.  Yi, T., A.L. Mui, G. Krystal, and J.N.  Ihle. 1993.  Hemato- 
poietic cell phosphatase associates with the interleukin-3 (IL-3) 
receptor  beta  chain  and  down-regulates  IL-3-induced ty- 
rosine phosphorylation and mitogenesis. Mol.  Cell.  Biol.  13: 
7577-7586. 
30.  Yi, T., andJ.N. Ihle. 1993. Association ofhematopoietic cell 
phosphatase with  c-Kit after stimulation with  c-Kit ligand. 
Mol.  Cell.  Biol.  13:3350-3358. 
31. Yeung,  Y.G.,  K.L.  Berg,  F.J.  Pixley,  R.H.  Angeletti, and 
E.R.  Stanley. 1992.  Protein tyrosine phosphatase-lC is rap- 
idly phosphorylated in tyrosine in macrophages in response to 
colony stimulating factor-l.J. Biol.  Chem. 267:23447-23450. 
32. Tsui,  F.W.,  and  H.W.  Tsui.  1994.  Molecular basis  of the 
motheaten phenotype. Immunol.  Rev.  138:185-206. 
33.  D'Ambrosio, D.,  K.L.  Hippen,  S.A. Minskoff,  I.  Mellman, 
G.  Pani,  K.A.  Siminovitch,  and J.C.  Cambier.  1995.  Re- 
cruitment and activation of PTPlC in negative regulation of 
antigen  receptor  signaling  by  Fc  gamma  RIIB1.  Science 
(Wash. DC). 268:293-297. 
34. Campbell,  M.-A.,  and  N.R.  Klinman.  1995.  Phosphoty- 
rosine-dependent association between CD22 and protein ty- 
rosine phosphatase 1C. Eur.J. Immunol.  25:1573-1579. 
35. Doody,  G.M.,  L.B.  Justement,  C.C.  Delibrias,  R.J.  Mat- 
thews, J. Lin, M.L. Thomas, and D.T. Fearon. 1995. Restric- 
tion of B lymphocyte activation by CD22 and the protein ty- 
rosine phosphatase SHP. Science (Wash. DC). 269:242-245. 
36. Cyster, J.G.,  and  C.C.  Goodnow.  1995.  Protein  tyrosine 
phosphatase 1C negatively regulates antigen receptor signal- 
ing in B lymphocytes and determines thresholds for negative 
selection. Immunity.  2:13-24. 
37.  Torres,  R.M.,  C.L.  Law,  A.L.  Santos,  P.A.  Kirkham,  K. 
Grabstein, R.M.  Parkhouse, and E.A. Clark.  1992.  Identifi- 
cation  and  characterization  of the  murine  homologue  of 
CD22,  a B  lymphocyte-restricted adhesion molecule. J.  Im- 
munol.  149:2641-2649. 
38.  Zhao,  Z.,  P.  Bouchard,  C.D.  Diltz,  S.H.  Shen,  and E.H. 
Fischer.  1993.  Purification and characterization of a protein 
tyrosine phosphatase containing SH2 domains. J.  Biol.  Chem. 
268:2816-2820. 
39. Law,  C.L.,  S.P.  Sidorenko,  K.A.  Chandran,  K.E.  Draves, 
A.C. Chan, A. Weiss, S. Edelhoff, C.M. Disteche, and E.A. 
Clark. 1994. Molecular cloning of human Syk. A B cell pro- 
tein-tyrosine kinase associated with the surface immunoglob- 
ulin M-B cell receptor complex. J.  Biol.  Chem.  269:12310- 
12319. 
40.  Field, J., J.  Nikawa, D. Broek, B. MacDonald, L. Rodgers, 
I.A. Wilson, R.A. Lemer, and M. Wigler. 1988.  Purification 
of a R.AS-responsive adenylyl cyclase complex from Saccharo- 
myces cerevisiae by use  of an  epitope addition method. Mol. 
Cell.  Biol.  8:2159-2165. 
41. Leprince, C., K.E. Draves, J.A. Ledbetter, R.M. Torres, and 
E.A. Clark. 1992.  Characterization of molecular components 
associated with surface immunoglobulin M  in human B lym- 
phocytes: presence of tyrosine and serine/threonine protein 
kinases. Eur. J. Immunol. 22:2093-2099. 
42. Chalupny, N.J., S.B. Kanner, G.L. Schieven, S.F. Wee, L.K. 
Gilliland, A. Aruffo, andJ.A. Ledbetter. 1993. Tyrosine phos- 
phorylation of CD19  in pre-B and mature B  cells.  EMBO 
(Eur.  Mol.  Biol.  Organ.)J.  12:2691-2696. 
43.  Tuveson, D.A., R.H.  Carter, S.P. Soltoff, and D.T.  Fearon. 
1993.  CD19  of B  cells as a surrogate kinase insert region to 
bind phosphatidylinositol 3-kinase. Science (Wash.  DC).  260: 
986--989. 
44. Schieven, G.L., J.M. Kirihara, D.L. Burg, R.L. Geahlen, and 
J.A. Ledbetter.  1993.  p72syk tyrosine kinase is activated by 
oxidizing conditions that induce lymphocyte tyrosine phos- 
phorylation  and  Ca  2+  signals. J.  Biol.  Chem.  268:16688- 
16692. 
45.  Schieven, G.L., R.S. Mittler, S.C. Nadler, J.M. Bolen, S.B. 
Kanner,  and J.A. Ledbetter.  1994.  ZAP-70 tyrosine kinase, 
CD45,  and T  cell receptor involvement in UV- and H202- 
induced T cell signal transduction.J. Biol.  Chem. 269:20718- 
20726. 
46.  Townley, R., S.H. Shen, D. Banville, and C. Ramachandran. 
1993.  Inhibition of the activity of protein tyrosine phosphate 
1C by its SH2 domains. Biochemistry.  32:13414-13418. 
47.  Pei,  D.,  U.  Lorenz,  U.  Klingmuller, B.C.  Neel,  and  C.T. 
Walsh.  1994.  Intramolecular regulation of protein tyrosine 
phosphatase SH-PTPI: a new function for Src homology 2 
domains. Biochemistry.  33:15483-15493. 
48.  Zhao,  Z.,  S.H.  Shen,  and E.H.  Fischer.  1993.  Stimulation 
by phospholipids of a protein-tyrosine-phosphatase containing 
two src homology 2 domains. Proc. Natl. Acad.  Sci.  USA.  90: 
4251-4255. 
49. Law, C.L., R.M.  Torres, H.A. Sundberg, R.M.  Parkhouse, 
C.I. Brannan, N.G. Copeland, N.A. Jenkins, and E.A. Clark. 
1993.  Organization of the murine Cd22  locus. Mapping to 
chromosome 7 and characterization of two alleles. J.  Immu- 
nol.  151:175-187. 
50. Burg,  D.L.,  M.T.  Furlong,  M.L.  Harrison,  and  R.L. 
Geahlen. 1994.  Interactions of Lyn with the antigen receptor 
during B cell activation.J. Biol.  Chem. 269:28136-28142. 
51.  Songyang,  Z.,  S.E.  Shoelson,  M.  Chaudhuri,  G.  Gish,  T. 
Pawson,  W.G.  Haser,  F.  King,  T.  Roberts,  S.  Ratnofsky, 
R.J. Lechleider, et al.  1993.  SH2 domains recognize specific 
phosphopeptide sequences. Cell.  72:767-778. 
52.  Songyang,  Z.,  S.E.  Shoelson, J.  McGlade,  P.  Olivier,  T. 
Pawson, X.R. Bustelo, M. Barbacid, H. Sabe, H. Hanafusa, 
T. Yi, et al. 1994.  Specific motifs recognized by the SH2 do- 
mains of Csk, 3BP2,  fps/fes, GRB-2, HCP,  SHC, Syk, and 
Vav. Mol.  Cell.  Biol.  14:2777-2785. 
53.  Saouaf,  S.J., S. Mahajan, R.B. Rowley, S.A. Kut, J. Fargnoli, 
A.L.  Burkhardt,  S.  Tsukada,  O.N.  Witte,  and J.B.  Bolen. 
1994.  Temporal differences in the activation of three classes 
of non-transmembrane  protein  tyrosine  kinases  following 
B-cell antigen receptor surface  engagement. Proc. Natl. Acad. 
Sci.  USA.  91:9524-9528. 
54. Maegawa, H., S. Ugi, O. Ishibashi, I.R. Tachikawa, N. Ta- 
559  Law et al. kahara,  Y. Tanaka, Y. Takagi, R. Kikkawa, Y. Shigeta,  and 
A. Kashiwagi.  1993.  Src homology 2 domains of protein ty- 
rosine phosphatase  are phosphorylated by insulin receptor ki- 
nase and bind to the COOH-terminus of insulin receptors in 
vitro. Biochem. Biophys. Res.  Commun.  194:208-214. 
55. Lorenz,  U.,  K.S.  Ravichandran,  D.  Pei,  C.T.  Watsh,  S.J. 
Burakoff,  and B.G. Neel. 1994. Lck-dependent tyrosyl phos- 
phorylation of the phosphotyrosine phosphatase  SH-PTP1 in 
murine T cells. Mol.  Cell. Biol. 14:1824-1834. 
56. Uchida, T., T. Matozaki,  T. Noguchi, T. Yamao, K. Horita, 
T. Suzuki,  Y. Fujioka,  C. Sakamoto, and M. Kasuga.  1994. 
Insulin stimulates the phosphorylation of Tyr538 and the cat- 
alytic activity of PTP1C, a protein tyrosine phosphatase  with 
Src homology-2 domains.J. Biol. Chem. 269:12220-12228. 
57. Vogel, W., R. Lammers, J. Huang, and A. UUrich. 1993. Ac- 
tivation of a phosphotyrosine phosphatase  by tyrosine phos- 
phorylation. Science (Wash. DC), 259:1611-1614. 
560  CD22-associating  Proteins in B cells 